Related Experiment Videos
Low plasma apolipoprotein A-I level: new prognostic criterion in childhood cirrhosis?
M A Selimoğlu1, S Aydoğdu, R V Yağci
1Gastroenterology and Nutrition Unit, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey.
Insights
Apolipoprotein A-I (apo A-I) levels can predict poor prognosis in children with cirrhosis. Lower apo A-I values indicate higher risk, aiding in early identification of severe disease progression.
Area of Science:
- Pediatrics
- Hepatology
- Biochemistry
Background:
- Apolipoprotein A-I (apo A-I) is decreased in adult cirrhosis but not routinely used for prognosis.
- Childhood cirrhosis lacks established biomarkers for predicting disease severity.
Purpose of the Study:
- To determine apo A-I levels in childhood cirrhosis.
- To establish prognostic cut-off values for apo A-I in pediatric cirrhosis.
Main Methods:
- Studied apo A-I levels in 78 children with chronic liver disease (38 with cirrhosis).
- Analyzed apo A-I correlations with Malatack's model, Child-Pugh score, bilirubin levels, and prothrombin time.
- Assessed apo A-I in cirrhotic children with and without cholestasis.
Main Results:
- Mean apo A-I levels did not differ between cirrhotic, non-cirrhotic, and healthy children.
- In cirrhotic children, apo A-I levels correlated inversely with disease severity (Malatack, Child-Pugh scores) and liver function markers.
- Lower apo A-I (< 80 mg/dl or < 83 mg/dl) showed high specificity and negative predictive value for high-risk groups (Malatack high-risk, Child-Pugh C).
Conclusions:
- Apolipoprotein A-I is a sensitive and specific indicator of poor prognosis in childhood cirrhosis.
- Apo A-I levels can aid in risk stratification and management of pediatric liver disease.
Abstract:
Apolipoprotein A-I (apo A-I) has been found to be decreased in adults with cirrhosis, but it has not been routinely used for prognostic purposes thus far. This study was performed to determine apo A-I levels in childhood cirrhosis and to establish some prognostic cut-off values. Apo A-I levels of 78 children with chronic liver disease, 38 of whom had cirrhosis as well, were studied. Mean values of cirrhotic, non-cirrhotic and healthy children were not different (p > .05). However, in cirrhotic children, the highest value was detected in the Child-Pugh A group, and it was different from those of the B and C groups (p < .05 and p < .001, respectively). Apo A-I was the lowest in the moderate risk group of Malatack's model, and was significantly different from the low risk group (p < .05). Apo A-I was inversely correlated with Malatack score, Child-Pugh score, total bilirubin, conjugated bilirubin, and prothrombin time (p < .01, p < .01, p < .01, p < .01, p < .05, respectively). In cirrhotic children with cholestasis, apo A-I was lower than in non-cholestatic children (p < .05). Apo A-I value < 80 mg/dl had 84% specificity and 84% negative predictive value for the high risk group of Malatack's model. Similarly, Apo A-I value < 83 mg/dl had 95% specificity and 87% negative predictive value for the Child-Pugh C group. We concluded that Apo A-I is a sensitive and specific parameter of poor prognosis in childhood cirrhosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction